Pune: Indigenous mRNA vax candidate’s clinical trials soon
Pune: The clinical trials of India’s first indigenous mRNA vaccine candidate — HGCO19 — to assess its safety and immunogenicity against Covid-19 could begin in...
Pfizer
Pfizer, BioNTech eye full FDA approval for COVID-19 vaccine as efficacy stands strong, including against aggressive variant
Pfizer and BioNTech offered an updated look at the efficacy of their COVID-19 vaccine, BNT162b2. The overall efficacy figure remained high at 91.3%, and the...
Pfizer Covid-19 vaccine safe, effective in kids aged 12 to 15, companies say
Pfizer Inc and BioNTech SE said on Wednesday their Covid-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds,...
Short-lived romance: Pharma industry facing heat for Covid vaccine failures, greed
The discovery of multiple safe and effective Covid-19 vaccines has been the reputational boost the pharmaceutical industry needed. As science has caught up to the...
BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 billion doses
BioNTech and Pfizer will boost manufacturing capacity of their Covid-19 vaccine to 2.5 billion doses by the end of 2021, BioNTech said on Tuesday, as...
Japan to allow people to choose COVID-19 vaccine
Image used for representational purpose only Tokyo: People in Japan will be given a choice of a coronavirus vaccine, a senior official in charge of...
CDMO Raybow adding 74 jobs in the hills of North Carolina at its U.S. headquarters
A budding CDMO in the Blue Ridge Mountains of North Carolina is ready to grow significantly. Over the next five years, Raybow Pharmaceuticals will invest...
BioNTech nabs EU approval for Novartis plant tapped in COVID-19 vaccine production push
On a quest to turn out 2 billion doses of their COVID-19 vaccine Comirnaty this year, Pfizer and BioNTech just scored a major boost thanks to...
Pfizer launches COVID-19 vaccine test in children as new data support mRNA shots in pregnant women
While COVID-19 shots have proven effective in clinical trials—and now in the real world, too—relatively little is known about how they work in children and pregnant women. Moderna, Pfizer and Johnson...
Pfizer, after success in COVID-19, will go solo to develop other mRNA vaccines, CEO Bourla says
On the heels of its rapid development of a COVID-19 vaccine, Pfizer will attempt to use the same gene-based technology to advance other vaccines against...